Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Rapid Dose Therapeutics Corp ( (TSE:DOSE) ) has issued an announcement.
Rapid Dose Therapeutics Corp. announced its intention to issue common shares to satisfy the accrued interest on its secured convertible notes as part of its private placement financing. This move, consistent with previous quarters, involves issuing 430,930 common shares at a price of $0.22 per share to cover $94,806.23 of accrued interest, reflecting the company’s commitment to structured financial strategies and stakeholder engagement.
More about Rapid Dose Therapeutics Corp
Rapid Dose Therapeutics Corp. is a Canadian biotechnology company focused on innovative drug delivery solutions. Its flagship product, QuickStrip™, is an orally dissolvable film designed for the rapid delivery of active ingredients such as nutraceuticals, pharmaceuticals, and vaccines directly into the bloodstream.
YTD Price Performance: 2.27%
Average Trading Volume: 53,197
Technical Sentiment Consensus Rating: Sell
Current Market Cap: C$28.04M
For a thorough assessment of DOSE stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money